Tilia Fiduciary Partners’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-600
| Closed | -$15.2K | – | 529 |
|
|
2023
Q2 | $15.2K | Hold |
600
| – | – | 0.01% | 330 |
|
|
2023
Q1 | $19.3K | Hold |
600
| – | – | 0.02% | 298 |
|
|
2022
Q4 | $11.1K | Hold |
600
| – | – | 0.01% | 354 |
|
|
2022
Q3 | $17K | Hold |
600
| – | – | 0.02% | 308 |
|
|
2022
Q2 | $9K | Hold |
600
| – | – | 0.01% | 395 |
|
|
2022
Q1 | $12K | Hold |
600
| – | – | 0.01% | 388 |
|
|
2021
Q4 | $10K | Buy |
+600
| New | +$10K | 0.01% | 416 |
|